Omada Health OMDA
Valuation
Multiples measured against the stock's own five-year history
Near the top of its 5-year range · 81st percentile, 5-year average -3.2x
#2677 of 2990 stocks by PE (1 = cheapest)
Below its usual level · 21st percentile, 5-year average 3.8x
#3875 of 5329 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 2nd percentile, 5-year average 4.4x
#2949 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 3.25 | – | 3.85 | 21% (cheaper than usual) | #3875 of 5329 (1 = cheapest) |
| PE | 63.41 | 46.13 | -3.21 | 81% (pricier than usual) | #2677 of 2990 (1 = cheapest) |
| PS | 2.67 | 2.26 | 4.40 | 2% (cheaper than usual) | #2949 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on OMDA.
Sign in to join the discussion.